Vault-13

Paradigm Biocapital Advisors LP

NEW YORK, NY · CIK 1855655 · 13F filing filed 2025-02-14

SEC-registered investment adviser since 2021 · limited partnership

As an employer

$2.9bn reported value +0.6% vs Q3 2024
28positions
73.6%in top 10
4 new 20 added 3 reduced 7 sold out vs Q3 2024

Holdings, Q4 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NUVALENT INC COM COM 5,363,379 $419.8m14.61% 14.61% AddedShares held: Q1 2024 4.2m, Q2 2024 4.6m, Q3 2024 5.0m, Q4 2024 5.4m +363.4k +363,379 7.3%
2 ARCELLX INC COMMON STOCK ACLX ACLX 4,371,601 $335.3m11.66% 11.66% AddedShares held: Q1 2024 3.8m, Q2 2024 3.8m, Q3 2024 4.0m, Q4 2024 4.4m +371.6k +371,601 9.3%
3 ARGENX SE SPONSORED ADR ARGX ARGX 481,305 $296.0m10.30% 10.30% AddedShares held: Q1 2024 552.1k, Q2 2024 538.1k, Q3 2024 480.4k, Q4 2024 481.3k +931 +931 0.2%
4 REVOLUTION MEDICINES INC COM RVMD RVMD 6,553,111 $286.6m9.97% 9.97% AddedShares held: Q1 2024 2.9m, Q2 2024 5.3m, Q3 2024 5.3m, Q4 2024 6.6m +1.2m +1,239,022 23.3%
5 JANUX THERAPEUTICS INC COM JANX JANX 3,515,986 $188.2m6.55% 6.55% AddedShares held: Q1 2024 0, Q2 2024 1.6m, Q3 2024 2.4m, Q4 2024 3.5m +1.1m +1,115,412 46.5%
6 TARSUS PHARMACEUTICALS INC COM TARS TARS 2,531,896 $140.2m4.88% 4.88% AddedShares held: Q1 2024 2.9m, Q2 2024 2.4m, Q3 2024 2.4m, Q4 2024 2.5m +91.5k +91,451 3.8%
7 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 4,493,929 $120.0m4.17% 4.17% AddedShares held: Q1 2024 2.4m, Q2 2024 2.3m, Q3 2024 2.8m, Q4 2024 4.5m +1.7m +1,704,757 61.1%
8 VAXCYTE INC COM PCVX PCVX 1,422,787 $116.5m4.05% 4.05% AddedShares held: Q1 2024 1.2m, Q2 2024 627.2k, Q3 2024 627.7k, Q4 2024 1.4m +795.1k +795,055 126.7%
9 BEIGENE LTD SPONSORED ADR ONC ONC 616,024 $113.8m3.96% 3.96% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 200.3k, Q4 2024 616.0k +415.7k +415,688 207.5%
10 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,910,761 $97.7m3.40% 3.40% ReducedShares held: Q1 2024 3.1m, Q2 2024 2.5m, Q3 2024 2.5m, Q4 2024 1.9m -605.9k -605,925 -24.1%
11 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 1,772,211 $96.0m3.34% 3.34% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 931.5k, Q4 2024 1.8m +840.7k +840,731 90.3%
12 DISC MEDICINE INC COM IRON IRON 1,497,720 $95.0m3.30% 3.30% UnchangedShares held: Q1 2024 2.4m, Q2 2024 2.7m, Q3 2024 1.5m, Q4 2024 1.5m
13 MERUS N V COM MRUS MRUS 1,689,922 $71.1m2.47% 2.47% ReducedShares held: Q1 2024 0, Q2 2024 2.0m, Q3 2024 2.5m, Q4 2024 1.7m -765.0k -764,995 -31.2%
14 VERA THERAPEUTICS INC CL A VERA VERA 1,437,339 $60.8m2.11% 2.11% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 1.1m, Q4 2024 1.4m +340.5k +340,488 31.0%
15 APOGEE THERAPEUTICS INC COM COM 1,283,766 $58.2m2.02% 2.02% AddedShares held: Q1 2024 330.0k, Q2 2024 330.0k, Q3 2024 701.8k, Q4 2024 1.3m +581.9k +581,949 82.9%
16 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 7,304,970 $42.6m1.48% 1.48% AddedShares held: Q1 2024 7.9m, Q2 2024 7.9m, Q3 2024 5.5m, Q4 2024 7.3m +1.8m +1,801,370 32.7%
17 PLIANT THERAPEUTICS INC COM PLRX PLRX 3,197,050 $42.1m1.46% 1.46% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 3.1m, Q4 2024 3.2m +92.6k +92,564 3.0%
18 IMMATICS N.V SHS IMTX IMTX 5,414,409 $38.5m1.34% 1.34% AddedShares held: Q1 2024 2.8m, Q2 2024 3.4m, Q3 2024 3.9m, Q4 2024 5.4m +1.5m +1,509,547 38.7%
19 COGENT BIOSCIENCES INC COM COGT COGT 4,917,412 $38.4m1.33% 1.33% AddedShares held: Q1 2024 0, Q2 2024 3.6m, Q3 2024 4.6m, Q4 2024 4.9m +307.6k +307,650 6.7%
20 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 1,527,205 $35.6m1.24% 1.24% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 1.3m, Q4 2024 1.5m +259.6k +259,624 20.5%
21 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 1,820,079 $34.9m1.21% 1.21% ReducedShares held: Q1 2024 5.0m, Q2 2024 2.9m, Q3 2024 2.9m, Q4 2024 1.8m -1.1m -1,075,610 -37.1%
22 Y-MABS THERAPEUTICS INC COM YMAB YMAB 4,236,346 $33.2m1.15% 1.15% AddedShares held: Q1 2024 2.2m, Q2 2024 3.9m, Q3 2024 4.1m, Q4 2024 4.2m +150.0k +150,000 3.7%
23 ERASCA INC COM ERAS ERAS 10,752,354 $27.0m0.94% 0.94% AddedShares held: Q1 2024 0, Q2 2024 7.2m, Q3 2024 10.7m, Q4 2024 10.8m +84.2k +84,213 0.8%
24 TECTONIC THERAPEUTIC INC COM TECX TECX 485,105 $22.4m0.78% 0.78% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 485.1k
25 LENZ THERAPEUTICS INC COM LENZ LENZ 770,455 $22.2m0.77% 0.77% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 770.5k
26 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 400,000 $17.3m0.60% 0.60% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 400.0k
27 ORUKA THERAPEUTICS INC COM ORKA ORKA 819,660 $15.9m0.55% 0.55% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 719.7k, Q4 2024 819.7k +100.0k +100,000 13.9%
28 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 276,439 $9.1m0.32% 0.32% NewShares held: Q1 2024 400.0k, Q2 2024 0, Q3 2024 0, Q4 2024 276.4k

Sold out since Q3 2024

SecurityTickerShares held beforeValue then
KURA ONCOLOGY INC KURA KURA 4,331,321 $84.6m4.3m shares
ARVINAS INC ARVN ARVN 2,339,961 $57.6m2.3m shares
IMMUNOVANT INC IMVT IMVT 1,362,827 $38.9m1.4m shares
CULLINAN THERAPEUTICS INC CGEM CGEM 2,321,013 $38.9m2.3m shares
KEROS THERAPEUTICS INC KROS KROS 525,037 $30.5m525.0k shares
PERSPECTIVE THERAPEUTICS INC CATX CATX 919,692 $12.3m919.7k shares
COMPASS PATHWAYS PLC CMPS CMPS 1,160,000 $7.3m1.2m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
OLEMA PHARMACEUTICALS INC OLMA · 13G · filed 2025-02-14 OLMA 10.0%≈ $92.9m 13G 2025-02-14
EDGEWISE THERAPEUTICS INC EWTX · 13G · filed 2026-08-14 EWTX 9.5%≈ $415.1m +3.3 pts 13G 2026-08-14
ACHIEVE LIFE SCIENCES INC ACHV · 13G · filed 2026-04-24 ACHV 9.2%≈ $64.7m new 13G 2026-04-24
ASSEMBLY BIOSCIENCES INC ASMB · 13G · filed 2026-08-14 ASMB 7.8%≈ $42.7m +2.4 pts 13G 2026-08-14
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-08-14 VRDN 6.1%≈ $123.5m +1.0 pts 13G 2026-08-14
TYRA BIOSCIENCES INC TYRA · 13G · filed 2026-09-17 TYRA 5.8%≈ $110.9m new 13G 2026-09-17
LEXEO THERAPEUTICS INC LXEO · 13G · filed 2026-08-14 LXEO 5.3%≈ $19.4m -3.0 pts 13G 2026-08-14
MBX BIOSCIENCES INC MBX · 13G · filed 2026-06-24 MBX 5.2%≈ $137.6m new 13G 2026-06-24
SPYRE THERAPEUTICS INC SYRE · 13G · filed 2026-10-01 SYRE 5.1%≈ $395.7m new 13G 2026-10-01
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-07-17 JBIO 5.1%≈ $69.0m new 13G 2026-07-17